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An Analysis of Infectious Failures
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JESSE THOMPSONI,ROBERT S. BENNION and HENRY A. PITT
Departments of Surgery, Olive View/UCLA Medical Center, UCLA School of Medicine, and The Johns Hopkins Hospital
To determine the factors responsible for therapeutic failures in acute cholangitis, a series of 127
patientswas analyzed. There were 64 females and 63 maleswhosemean agewas 57.2 years. Ninety-
four (74.0%) ofthese patients were clinically cured with initial measures, whereas 33 patients (26%)
failed initial therapy foran infectious reason.No differences were observed between thetwo groups in
regard to age and gender. However, more patients in the group that failedhad a malignant cause for
their bile duct obstruction (72.7% vs. 42.6%, p < 0.01) andhad a pretreatment positive blood culture
(45.5% vs. 13.8%, p < 0.01). Patientswho failed had a highermean total bilirubin level (9.7 mg/dl vs.
5.5 mg/dl, p < 0.005) andmore ofthemhad a level greater than 2.2 mg/dl (97% vs. 69.9%, p < 0.001).
Also, more bile cultures were initially positive (93.9% vs. 76.6%, p < 0.05) andmore organismswere
isolated per culture (3.88 vs. 2.86, p < 0.03) in the patientswho failed. In addition,more patients failed
who hadtwo ormore organisms in the bile(33% vs. 8.3%, p < 0.02). Patients inwhom Candida, orany
panresistantorganismwas isolated also tended to fail. Multivariant analysis showed thatmalignancy,
bacteremia, bilirubin> 2.2 mg/dl, > 2 organisms in the bile and a panresistant organismwere the best
predictors oftreatment failure witha serum bilirubin level > 2.2 mg/dl being the variable that increases
a patient’s log-odds ratio offailure the greatest. In conclusion, patients with acute cholangitiswho
have an increased chance to fail initial therapy can be identified, and treatment altered accordingly.
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Acute cholangitis is infection in an obstructed biliary
system from both benign and malignant causes. Initial
therapy is directed toward general support ofthe patient
including fluid and electrolyte replacement, correction of
metabolic derangements, broad spectrum antibiotic
therapy, and biliary drainage. The majority ofpatientswith
acute cholangitis are cured of their infection by these
efforts. However, there are patients in whom this early
treatment ofcholangitis fails andwho require alteration in
therapy, such as a change in antibiotics, further biliary
drainage, or treatment ofan intervening infection like a
wound infection or pneumonia. The factors involved in
these infectious failures are not completely clear, and the
purpose ofthis study is to analyze a series ofpatients with
acute cholangitis to elucidate those elements that play a
role in patients who fail initial therapy for an infectious
cause.
Addressfor correspondence." JesseThompson, M.D., Departmentof
Surgery, Olive View/UCLA Medical Center, 2B156, 14445 Olive
View Drive, Sylmar, California 91342.
PATIENTSANDMETHODS
Patient Selection
The patients were selected from among those with acute
cholangitis treated at the University ofCalifornia at Los
Angeles Medical Center and the Olive View/UCLA
Medical Center in Los Angeles, California, and the Johns
Hopkins Medical Center in Baltimore, Maryland, in a
prospective fashion on two consecutive antibiotic proto-
colsfrom 1984 to 1988. The antibiotic regimens employed
were either a penicillin/aminoglycoside combination or a
broad spectrum penicillin, both of which have been
proven effective in,treating acute cholangitis -. The inclu-
sion criteria were a clinical diagnosis ofacute cholangitis
supported by either pain or tenderness in the right upper
quadrant orjaundice, and hypothermia of less than 36.5
degrees C.; fever of more than 38.0 degrees C.; septic
shock; or white blood cell (WBC) count of more than
10 x 109/L. Patients were not included ifanother medical
or surgical illness could explain the illness. All patients
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included in this study had obstruction ofthe biliary tract
documented roentgenographically and/or at surgery.
Patient Evaluation
Pretreatment blood cultures were obtained from all
patients. Aerobic and anaerobic bile cultures were
obtained from indwelling biliary tubes at the time ofper-
cutaneous draining, or at surgeryand were transported to
themicrobiology laboratory in anaerobic transport media.
All antibiotics were given intravenously foraminimum of
five days unless a clinical infectious failure occurred at
which time the antibioticswere usually changed.
A,patientwas considered a clinical cure ifthe signs and
symptoms of cholangitis completely abated with no
evidence of infection in the follow-up period. A patient
wasjudged improved if there was a signifcant improve-
ment in the clinical findings, but notcomplete resolution of
the infection. The relapse category was used for patients
who initially improved only tohave recurrence ofinfection
within three weeks oftherapy.A failure was defined as no
demonstrable response to therapy or the development ofa
significant postoperative infection in patients undergoing
an operation. Abdominal wounds were considered infe-
cted ifpurulent material that subsequently grew organisms
on culture could be obtained from them.
StatisticalAnalysis
Student’s two-tailed t-test and the chi-square test were
used to compare the differences between the study groups
and treatment results. Logistic regression analysis was
employed to evaluate the relative importance of the
differences observed between the study groups for the
individual variables. The data are expressed asmean (plus
or minus standard error of the mean) or as a percent of
patients.
Demographics
There were 127 patients with acute cholangitis eligible
for analysis. The number of patients in the improved
and relapse categories was too small for valid statistical
analysis, and these patients were included in the clinical
cure and failure groups, respectively. Therefore, 94
patients (74%) had a clinical cureand 33 (26%)werejudged
to be a clinical failure. The reasons for failure were persis-
tent sepsis in 28 patients (85%) and a wound infection in
five patients (15%).
The mean age of the patients in this series was 57.2
years, and there were 64 females (50.4%) and 63 males
(49.6%). There were no differences between the cure and
failure groups with regard to age or gender. In the cured
group themean agewas 56.8 + 1.5 years and there were 47
females (50%) compared to amean age of58.4 + 1.9 years
and 17 females (51.5%) in the failure group. No difference
was observed in the admitting temperature between the
two groups (38.5 + 0.08 C in those patients who were
cured vs. 38.8 + 0.15C in thosewho failed).
Sixty-three patients in this serieshad a benign cause for
their bile duct obstruction (stones-43, stricture- 15, sderos-
ingcholangitis -3, other-2), and 64hadamalignantetiology
(bile duct cancer 41, pancreatic cancer- 11, colon cancer-
4, gallbladdercancer -3, other-5). Nearly three-fourths (24/
33) of the failure patients had a malignant obstruction
compared to only 43% (40/94) of the cured patients
(p < 0.01).
The comorbidities present in the patients in this series
are listed in Table 1. The hematopoietic disease observed
in these patients was generally chronic anemia although
one patient in the failure group had hypersplenism and
one in the cured group had polycythemia vera. Patients
were considered to have cardiac disease iftheyhad under-
lying coronary artery disease, valvular heart disease or
congestive heart failure and hepatic disease if they had
documented cirrhosis or hepatitis. The renal disease refers
to preexisting chronic renal failure. No differences were
noted between the groups as 72 patients (76.6%) in the
cured group had a major comorbidity, while 23 patients
(69.7%) in the failure group were so afflicted.
Three patients in this series presented in septic shock, 2
(6%) in the group that failed and (1%) in the group that
was cured. In addition 3 patients (11%), all in the failure
group, had mild acute reversible renal failure associated
with their attack of acute cholangitis. The finding was
significant (p < 0.03).
LzoratoryData
The laboratory data is shown in Table 2. The two groups
were similar with respect to initial white blood cell count,
Table I Major comorbidities in patients with acute cholangitis
Cured Failure
(N=94) (N=33)
Hypertension 19 (20.2%) 10 (30.3%)
Hematopoietic 14 (14.9%) 4 (12.1%)
Diabetes 14 (14.9%) 3 (9.1%)
Cardiac 13 (13.8%) 7 (21.2%)
Pulmonary 12 (12.8%) 2 (6.1%)
Hepatic 8 (8.5%) 4 (12.1%)
Renal 5 (5.3%) 0
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alkalinephosphatase, SGOT, SGFr, creatinine, andBUN.
The only significant difference observedwas a higher total
bilirubin level in the failure group (9.7 + 1.3 mg/dl vs. 5.5 +
0.5 mg/dl, p < 0.005). In addition, more patients in the
group that failedhad a total bilirubin level greaterthan 2.2
mg/dl(97% vs. 69.9%, p <0.001).
OperationsandProcedures
In addition to antibiotic treatment, biliary drainage was
liberally employed in the patients in this series. Biliary
drainage tubes, primarily of the transhepatic type, were
the mostcommon modality employed, and were used to
stent anastomoses and palliate malignancies as well as to
drain infected bile. More patients in the failure group had
tube drainage compared to those that were cured (90.9%
vs. 60.6%, p < 0.001). The vastmajority ofthese tubeswere
already present prior to the attack of acute cholangitis,
and treatment included irrigation, replacement, and
repositioning. There were only two patients in the failure
group inwhom complete drainage ofthe biliary tractwas
probably not accomplished, and bothhad an unresectable
malignancy.
Concerning operations and other types ofinvasive pro-
cedures exclusive ofbiliary tube drainage, no differences
were noted between the two study groups. In the group
that was cured, 50% of patients had such a procedure
compared to 51.5% ofthosewho failed. The specific pro-
cedures are shown in Table 3.
Bacteriology
Twenty-eight patients (22%) in this series had a positive
blood culture associated with their attack of acute
cholangitis, and this bacteremia occurredmore frequently
in the failure patients (45.5% vs. 13.8%, p < 0.01). Inmost
instances, the same organism found in the blood was
eventually recovered from the bile. In addition, 103
patients (81.1%) had bactibilia on the initial bile culture,
Table 2 Laboratory data in patients with acute cholangitis
Cured Failure
(N=94) (N=33)
WBC (109/L 14.0+0.7 14.6 + 1.5
Bilirubin (MG/DL) 5.5 + 0.5* 9.7 + 1.3"
Alk Phos (IU) 481.6 + 38.8 491.4+ 47.2
SGOT (IU) 130.4 + 20.2 88.4 + 9.9
SGPT (IU) 136.6 + 21.4 92.3 + 10.4
BUN (MG/DL) 13.6 +0.8 15.0+ 1.8
Creatinine (MG/DL) 1.0 + 0.03 1.1 + 0.1
Table 3 Operations and procedures in patients with acute
cholangitis
Cured Failure
(N=94) (N=33)
Cholecystectomy, CBDE 20(21.3%) 2(6.1%)
Cholecystectomy 9 (9.6%) 2 (6.1%)
Choledochojejunostomy 7 (7.4%) 5 (15.2%)
ERCP-/-Sphincterotomy 4 (4.3%) (3.0%)
Percutaneous Drain Abscess 4 (4.3%) (3.0%)
Choledochoduodenostomy 2 (2.1%) (3.0%)
Exploratory Laparotomy (1.1%) 4 (12.1%)
Whipple Procedure 0 (3.0%)
and the failure patients were more likely than those who
were cured to have a positive culture (93.9% vs. 76.6%, p <
0.05). The patientswho failed alsohadmore organisms per
specimen (3.88 vs. 2.86, p < 0.03), and more ofthem had
two ormore organisms in the bile (33% vs. 8.3%, p < 0.02).
The actual organisms cultured from the bile in the two
groups of patients are shown in Table 4. There was a
tendency for Enterobacter, Streptococcus sp, and Candida
to be present more often in the failure patients, but this
tendency was significant only for Candida (27.3% vs.
10.6%, p < 0.05). Other types ofyeast were isolated occa-
sionally in this series, and all yeast as a group was also
present significantlymore often in the patientswho failed
(33% vs. 11.7%, p < 0.02).
No pure cultures ofanaerobic organisms were isolated
in this series ofpatients, and there was the same percent-
age ofmixed aerobic/anaerobic cultures in the two groups
(18.2% in the failure patients and 17.0% in the cured pa-
tients). Most patients had pure aerobic cultures. Eight
patients, each with at least three bacteria in their bile
culture, were found to have an organism resistant to all
antibiotics tested for. Five of these patients failed, three
were cured (15.2% vs. 3.2%, p < 0.05), and all had a malig-
nant etiology. Lastly, no particular combinations of
Table 4 Organisms recovered from the bile in patients with
acute cholangitis
Cured Failure
(N=94) (N=33)
E. coli 39.3% 48.5%
Enterococcus 45.7% 42.4%
Klebsiella 39.3% 36.4%
Enterobacter 21.3% 33.3%
Streptococcus 11.7% 30.3%
Pseudomonas 21.3% 27.3%
Candida 10.6%* 27.3%*
Citrobacter 14.9% 18.2%
Bacteroides 11.7% 12.1%
Clostridia 5.3% 12.1%
p < 0.005 * p < 0.005142 JESSETHOMPSON et al.
organisms were isolated more frequently in the failure
patients.
Most ofthe patientswho failedhad repeat bile cultures;
and as expected, there was persistence of the prevalent
organisms and a tendency toward increasing antibiotic
resistance, which was particularly evident with Enter-
obacter and Pseudomonas. Also there was a tendency to
isolate yeast more often in repeat bile cultures, although
thiswas not statistically significant(44% vs. 33%).
When patients were grouped by benign or malignant
etiology oftheir cholangitis, itwas evident that there were
major differences in the organisms encountered. Specifi-
cally, Pseudomonas sp, Enterobacter sp, Enterococcus sp,
Klebsiella sp, and all yeast were encountered significantly
more frequently in patients with malignancies (p < 0.005
for each). It should be noted that only one patient with a
benigncause for cholangitishad yeaston the initial culture
(p < 0.00001).
Deathsand Complications
Five patients (4%) in this series died during the
hospitalization for acute cholangitis, and each had a
malignant bile duct obstruction. No significant difference
in mortality was noted between the patients who were
curedand thosewho failed (3.2% vs. 6.1%). Hepatic failure
was a factor in the death of all five patients.
The major complications encountered in this series
were transient renal toxicity and hematopoietic toxicity,
whichwas manifest as an elevated prothrombin or partial
thromboplastin time.A greater percentage ofpatients in
the failure group developed a complication (21.2% vs.
9.6%) as well as renal (12.1% vs. 6.4%) or hematopoietic
(15.2% vs. 5.3% ), but these differenceswere not significant.
Five patients in this serieshad liver abscesses, and there
were no differences between the groups, as four of these
patients (4.3%) were cured and one (3%) was a failure.
MultivariantAnalysis
Table 5 Odds ratio of failure in patients with acute cholangitis
Parameter Odds Ratio
Malignanacy 1.93
Panresistant organism 3.55
Bacteria _> 2 5.93
Bacteremia 8.14
Elevated Bilirubin 30.11
failure. In addition, a serum bilirubin level _> 2.2 mg/dl is
the one variable that increases an individual patient’s log-
odds ratio of failure the greatest, when all the other
variables are corrected for. These log-odds ratios for all
five parameters are shown in Table 5.
Applying the mathematicalmodel for the parameters of
malignancy, positive blood culture, bilirubin level >_ 2.2
mg/dl, and multiple ( >_ 2) organisms in the bile produces
the predicted probabilities for failure exhibited in Table 6.
The presence ofpanresistant organisms is purposely ex-
cluded as this information is generally not available within
a time frame to be clinically useful. As shown, if all four
parameters are absent, there is a4% predicated probability
of failure, whereas when all four are present, there is a
greater than99% predicted probability offailure. In addi-
tion, bilirubin level alone ismore predictive offailure than
malignancy alone orcombined with either positive blood
culture or multiple organisms in the bile.
DISCUSSION
The purpose of this review was to identify in a
retrospective fashion those factorsinvolved in infectious
treatment failures in patients with acute cholangitis.
Of note, three of the five most significant variables
identified by multivariant analysis, i.e. positive blood
Table 6 Probability of failure in patients with acute cholangitis
Malignancy Bacteremia Elevated Bacteria 22 % Failure
Bilirubin
The results reported above suggest that the single
variables ofmalignancy, positiveblood culture, acute renal
failure, bactibilia, multiple organisms in the bile, yeast and
panresistant organisms in the bile, elevated bilirubin level,
and biliary drainage tubes are risk factors influencing
treatment failure in patients with acute cholangitis.
Multivariant analysis was performed using logistic
regression to analyze the relative significance of these
variables as risk factors both independently and in
combination. It was found that various combinations of
positive blood culture, malignancy, bilirubin _> 2.2 mg/dl,
multiple ( 2) organisms in the bile, and panresistant
organisms in the bile are the best predictors oftreatment
4.0
8.3
21.4
24.6
37.1
41.4
52.8
68.0
70.7
82.1
87.9
89.7
94.0
94.9
98.3
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culture, > 2 organisms in the bile, and the presence of a
panresistant organism in the bile, are infectious
parameters. The white blood cell count, temperature, age
and gender, which have been useful predictors of more
serious illness or adverse events in some analyses,
4-6 were
not discriminatory in this study.
A serum bilirubin level greater than 2.2 mg/dl was the
factor that increased an individual patient’s odds offailure
the most. The role ofjaundice or hyperbilirubinemia in
increasing postoperative morbidity and mortality in pa-
tients undergoing biliary tract surgery has not been com-
pletely elucidated..Several reports suggest that an elevated
bilirubin is related to the development of postoperative
complicationsand operative mortality,
5-8 andsome studies
have shown that reducing the bilirubin level preopera-
tively in patients with obstructivejaundice can reduce the
incidence of postoperative complications and death9,1.
Other reports, though, have shown that preoperative re-
duction ofthe bilirubin level has no impact on postopera-
tive problems,12. In addition, it is suggested in one study
thatjaundice per se does not contribute substantially to an
undesirable postoperative outcome 13. In this study, the
determinant of poor outcome was an infectious failure
following initial therapeuticmeasures for acute cholangi-
tis. It is known that patients with chronic obstructive
jaundice have impaired neutrophil functions and other
host defense mechanisms such as synthesis ofacute-phase
proteins andcomplement14,and conceivably these deficits
were operative in some patients in this series.
A malignant etiology for bile duct obstruction is an-
othermajor variable that increased the chance offailure in
this study. There seems to be rather universal agreement
that malignancy correlates with poor results in patients
with obstructivejaundicewho have surgery, with or with-
out infection5-7,13,5. It is also well recognized that both
cellular and humoral immunity are impaired either be-
cause of the underlying malignancy and/or the antine-
oplastic therapy6. In addition, malnutrition is a frequent
complication ofmalignancy which further decreases host
defense. This level ofimmunocompromise in patients with
cancermakes themmore susceptible to infectious compli-
cations such as acute cholangitis, andmakes the treatment
ofthese problems all the more difficult.
Bacteremia is a frequent occurrence in patients with
acute cholangitis as evidencedby the22% incidence in our
patients. It has been shown that obstructivejaundice can
promote bacterial translocationfrom the gut in an animal
model, possibly by an impairment in the mucosal barrier
function, as well asby impairedhostimmune defenses17. It
is not known if this leads to bacteremia or bactibilia or
both. The bacteremiamay also arise from an obstructed,
colonized bile duct. Since dissemination ofmicroorgan-
isms into the circulationcan resultwhen local host defense
mechanisms fail anywhereTM, bacteremia is a natural conse-
quence of acute cholangitis in many patients. It is not
surprising that bacteremia was a significant predictor of
infectious failure in our patients. Dissemination of mi-
crobes via the blood stream will activate the systemic
inflammatory responsewhichcan be a potential host liabil-
ity ifmultiorgan failure intervenes8.
Most patients in this series had bactibilia. The organ-
isms isolated are similar to those that have been reported
by others9-22. Like these reports, multiple organisms were
isolatedfrom the bile in the majority ofthe patients in this
study. However, those patients inwhom the bile cultures
grewtwo ormore organisms were at greater risk offailure
than those patientswhose cultures grew none or, at most,
one organism. Since a sterile bile culture could be inter-
preted as eradication ofinfection, one would expect these
patients to have less infectious sequelae following ad-
equate therapy. Moreover, the presence oftwo or more
organisms might be an indication ofa greater infectious
burden or bacterial synergy, both ofwhich are more dif-
ficult to treat, especially in patientswho arejaundiced and/
orhave an underlyingmalignancy.
The only organisms thatwere present significantlymore
often in the patientswho failedwere panresistant ones and
yeast. In our experience complete eradication of all the
organisms in the bile is uncommon, even in those patients
who are cured oftheir acute infectious illness. Complete
eradicationwould be particularly difficult to achieve for a
patient with either a panresistant organism or a tenacious
opportunistic pathogen such as yeast.A bile culture con-
taining a panresistant organismwas one ofthe major de-
terminants offailure in the multivariant analysis. It should
be noted that Enterococcuswas present in the bile culture
ofthe failure patients at least as often as the other major
pathogens such as E. coli and Klebsiella, but its signifi-
cance regarding predilection for failurewas not apparent.
Whether Enterococcus is amajorpathogen innon-nosoco-
mial intra-abdominal infection has not been completely
23 elucidated and the results of the current study do not
help to clarify this question.
Biliary drainage tubes were present inmany ofthe pa-
tients in this series and were used for a variety of indica-
tions, including drainage ofinfected bile and stenting of
unresectablemalignancies ortenuous anastomoses. Many
times in this series occlusion or some othermalfunction of
the tube was the initiating event in the development ofan
attack of acute cholangitis. Irrigation, repositioning, or
even replacement was often required to control the infec-
tion. Even though the presence ofa biliary tube was not
one ofthemost important factors influencing an infectious
failure following initial treatment of acute cholangitis,144 JESSETHOMPSON et al.
tubes in general do complicate matters. First, they are a
foreign body generally draining to the outside providing
easy access offlora into the biliary tract andmakingcom-
plete eradication impossible, and second, they precipitate
repeat attacks ofacute cholangitis in some patients who
then receive numerous courses of antibiotics5. In addi-
tion, some clinicians place these patients on long-term
suppressive oral antibiotic therapy which can lead to the
development ofresistant organisms and the emergence of
opportunisticpathogens, particularly yeast.
Complications of therapy and death were somewhat
more prevalent in those patientswho were infectious fail-
ure in this series than in those who were cured, but these
differences were not significant. One would expect pa-
tients withmore serious infections to havemore problems,
but this trend could notbe fullydocumented in this report.
S
A series of patients with acute cholangitis has been
analyzed. For those patientswho do not respond to initial
therapy, several risk factors have been identified. The
most important of these are a serum bilirubin greater
than 2.2 mg/dl, bacteremia, a malignant cause ofthe bile
duct obstruction, two or more organisms in the bile
culture, and a panresistant organism in the bile. Most of
these parameters are generallyknown within the first48 to
72 hours of therapy. Therefore, early in the course of
treatment, the clinician should be alerted to the possibility
that the patient with two or more of these risk factors
has a greater chance to fail, and be prepared to alter
the treatment plan. Such alterations should include bro-
adening or changing the antibiotic coverage, increased
diligence in monitoring for signs ofimpending sepsis, and
assuring adequate and complete drainage of the biliary
tract.
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INVITEDCOMMENTARY
An AnalysisOfInfectious Failures In Acute Cholangitis
Acute cholangitis is still associated with a substantial
morbidity and mortality despite improvements inmodem
antibiotic therapy and intensive care treatment. The
identification offactors predisposing to treatment failure
should thus of great clinical value. The present study
demonstrates that high bilirubin levels, positive bile
cultures, multiple bacterial growth, positive blood cultures
prior to treatment and malignancy correlate with a higher
risk oftreatment failure in acute cholangitis. The finding of
increased bilirubin level, reported to. the most important
factor, could have several explanations. Biliary obstru-
ction induces a variety ofalterations in host defense, such
as an impairment inRES function particularly Kupffer cell
function-3. This could be due to factors like increased
intraductal pressure, increased plasma concentrations of
antimetabolic substances or depletion ofserum opsonins
otherwise promoting phagocytosis. Furthermore,
increased bilirubin levelsby inhibiting cellular respiratory
enzymes might impair energy dependent phagocytosis 4.
The endotoxemia noted in patients with obstructive
jaundice probably also has an influence, e.g. by inducing
macrophage dysfunction5,6 and the lack of intestinal
luminal bile salts in biliary obstruction also increases endo-
toxemia as bile salts possess a direct detergent effect on
endotoxin7. The presence ofbiliary obstruction might also
constitute a hindrance to hepatocyte excretion and it
might thus be more difficult to obtain the required con-
centrations ofantibiotics in bile.
The present study demonstrates bactibilia as a factor
predisposing to treatment failure. In patients with com-
mon bile duct stones and acute suppurative chotangitis,
bacterial cultures from bile seem to be always positive 8,9. It
is to be emphasized that anaerobic bacteria, mainly Clos-
tridium and Bacteroides, with improved culture techniques
are demonstrated in maybe 20-30% of positive
cultures.. Thus, antibiotics also covering the anaerobic
flora should be considered. Otherwise, as also demon-
strated in the present study, bacterial culture findings
fairly well represent bacteria present in the distant small
intestine 12,13. The use of biliary drainage tubes tended,
though not significantly, to predispose to treatment
failures. Septic events following both percutaneous tran-
shepatic drainage and endoscopic biliary drainage are
frequent
14,5 and reported factors predisposing to the de-
velopment ofcholangitisfollowing the use ofbiliary drain-
age are among others malignancy, duration of biliary
drainage and incomplete bile drainage 14,16. In order to
improve the outcome ofpatients with acute cholangitis,
the definition offactors predisposing to treatment failure
are ofgreat clinical usefulness. Patients at high risk need
special consideration and might qualify formore intense
and extensive treatment from the very beginning.
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